Morten Kranker Larsen (Morten K Larsen)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 22

Top Topics

Cardiovascular Events

Ulcerative Colitis

Epidermal Growth Factor Receptor

Peripheral Blood

Top Venues

Blood cancer journal

European journal of haematology

British journal of haematology

This page only lists publications with an associated author ORCID identifier.

Publications

Christina Schjellerup Eickhardt-Dalbøge, Henrik Vedel Nielsen, Kurt Fuursted, Christen Rune Stensvold, Lee O' Brien Andersen, Berit Lilje, Morten Kranker Larsen, Lasse Kjaer, Sarah Friis Christensen, Trine Alma Knudsen, Vibe Skov, Anders Lindholm Sørensen, Christina Ellervik, Lars Rønn Olsen, Jens Jørgen Elmer Christensen, Xiaohui Chen Nielsen, Hans Carl Carl Hasselbalch, Anna Cäcilia Ingham
JAK2V617F drives gut microbiota differences in patients with myeloproliferative neoplasms. European journal of haematology 112 (5) (2024)
Hans Carl Carl Hasselbalch, Marie Hvelplund Kristiansen, Lasse Kjaer, Vibe Skov, Morten Kranker Larsen, Christina Ellervik, Troels Wienecke
CHIP-JAK2V617F, chronic inflammation, abnormal megakaryocyte morphology, organ failure, and multimorbidties. Blood advances 8 (3) (2024)
Christina Schjellerup Eickhardt-Dalbøge, Henrik Vedel Nielsen, Kurt Fuursted, Christen Rune Stensvold, Lee O' Brien Andersen, Berit Lilje, Morten Kranker Larsen, Lasse Kjaer, Sarah Friis Christensen, Trine Alma Knudsen, Vibe Skov, Anders Lindholm Sørensen, Christina Ellervik, Lars Rønn Olsen, Jens Jørgen Elmer Christensen, Xiaohui Chen Nielsen, Hans Carl Carl Hasselbalch, Anna Cäcilia Ingham
JAK2V617F drives gut microbiota differences in patients with myeloproliferative neoplasms. European journal of haematology 112 (5) (2024)
Hans Carl Carl Hasselbalch, Marie Hvelplund Kristiansen, Lasse Kjaer, Vibe Skov, Morten Kranker Larsen, Christina Ellervik, Troels Wienecke
CHIP-JAK2V617F, chronic inflammation, abnormal megakaryocyte morphology, organ failure, and multimorbidties. Blood advances 8 (3) (2024)
Anders Lindholm Soerensen, Vibe Skov, Lasse Kjær, Mads Emil Bjørn, Christina Schjellerup Eickhardt-Dalbøge, Morten Kranker Larsen, Claus Henrik Nielsen, Carsten Thomsen, Lise-Mette Rahbek Gjerdrum, Trine Alma Knudsen, Christina Ellervik, Ulrik Malthe Overgaard, Christen Lykkegaard Andersen, Hans Carl Carl Hasselbalch
Combination Therapy with Ruxolitinib and Pegylated Interferon-alpha2a in Newly Diagnosed Patients with Polycythemia Vera. Blood advances (2024)
Morten Kranker Larsen, Vibe Skov, Lasse Kjær, Christina Schjellerup Eickhardt-Dalbøge, Trine Alma Knudsen, Marie Hvelplund Kristiansen, Anders Lindholm Sørensen, Troels Wienecke, Morten Andersen, Johnny T Ottesen, Johanne Gudmand-Høyer, Jordan Andrew Snyder, Mikkel Porsborg Andersen, Christian Torp-Pedersen, Henrik Enghusen Poulsen, Thomas Stiehl, Hans Carl Carl Hasselbalch, Christina Ellervik
Neutrophil-to-lymphocyte ratio and all-cause mortality with and without myeloproliferative neoplasms-a Danish longitudinal study. Blood cancer journal 14 (1) (2024)
Morten Kranker Larsen, Vibe Skov, Lasse Kjær, Christina Schjellerup Eickhardt-Dalbøge, Trine Alma Knudsen, Marie Hvelplund Kristiansen, Anders Lindholm Sørensen, Troels Wienecke, Morten Andersen, Johnny T Ottesen, Johanne Gudmand-Høyer, Jordan Andrew Snyder, Mikkel Porsborg Andersen, Christian Torp-Pedersen, Henrik Enghusen Poulsen, Thomas Stiehl, Hans Carl Carl Hasselbalch, Christina Ellervik
Neutrophil-to-lymphocyte ratio and all-cause mortality with and without myeloproliferative neoplasms-a Danish longitudinal study. Blood cancer journal 14 (1) (2024)
Morten Kranker Larsen, Vibe Skov, Lasse Kjær, Christina Schjellerup Eickhardt-Dalbøge, Trine Alma Knudsen, Marie Hvelplund Kristiansen, Anders Lindholm Sørensen, Troels Wienecke, Morten Andersen, Johnny T Ottesen, Johanne Gudmand-Høyer, Jordan Andrew Snyder, Mikkel Porsborg Andersen, Christian Torp-Pedersen, Henrik Enghusen Poulsen, Thomas Stiehl, Hans Carl Carl Hasselbalch, Christina Ellervik
Neutrophil-to-lymphocyte ratio and all-cause mortality with and without myeloproliferative neoplasms-a Danish longitudinal study. Blood cancer journal 14 (1) (2024)
Morten Kranker Larsen, Vibe Skov, Lasse Kjær, Christina Schjellerup Eickhardt-Dalbøge, Trine Alma Knudsen, Marie Hvelplund Kristiansen, Anders Lindholm Sørensen, Troels Wienecke, Morten Andersen, Johnny T Ottesen, Johanne Gudmand-Høyer, Jordan Andrew Snyder, Mikkel Porsborg Andersen, Christian Torp-Pedersen, Henrik Enghusen Poulsen, Thomas Stiehl, Hans Carl Carl Hasselbalch, Christina Ellervik
Neutrophil-to-lymphocyte ratio and all-cause mortality with and without myeloproliferative neoplasms-a Danish longitudinal study. Blood cancer journal 14 (1) (2024)
Hans Carl Carl Hasselbalch, Marie Hvelplund Kristiansen, Lasse Kjaer, Vibe Skov, Morten Kranker Larsen, Christina Ellervik, Troels Wienecke
CHIP-JAK2V617F, chronic inflammation, abnormal megakaryocyte morphology, organ failure, and multimorbidities. Blood advances 8 (3) (2024)
Christina Schjellerup Eickhardt-Dalbøge, Henrik Vedel Nielsen, Kurt Fuursted, Christen Rune Stensvold, Lee O' Brien Andersen, Berit Lilje, Morten Kranker Larsen, Lasse Kjaer, Sarah Friis Christensen, Trine Alma Knudsen, Vibe Skov, Anders Lindholm Sørensen, Christina Ellervik, Lars Rønn Olsen, Jens Jørgen Elmer Christensen, Xiaohui Chen Nielsen, Hans Carl Carl Hasselbalch, Anna Cäcilia Ingham
JAK2V617F drives gut microbiota differences in patients with myeloproliferative neoplasms. European journal of haematology (2024)
Morten Kranker Larsen, Vibe Skov, Lasse Kjær, Christina Schjellerup Eickhardt-Dalbøge, Trine Alma Knudsen, Marie Hvelplund Kristiansen, Anders Lindholm Sørensen, Troels Wienecke, Morten Andersen, Johnny T Ottesen, Johanne Gudmand-Høyer, Jordan Andrew Snyder, Mikkel Porsborg Andersen, Christian Torp-Pedersen, Henrik Enghusen Poulsen, Thomas Stiehl, Hans Carl Carl Hasselbalch, Christina Ellervik
Neutrophil-to-lymphocyte ratio and all-cause mortality with and without myeloproliferative neoplasms-a Danish longitudinal study. Blood cancer journal 14 (1) (2024)
Hans Carl Carl Hasselbalch, Marie Hvelplund Kristiansen, Lasse Kjaer, Vibe Skov, Morten Kranker Larsen, Christina Ellervik, Troels Wienecke
CHIP-JAK2V617F, chronic inflammation, abnormal megakaryocyte morphology, organ failure, and multimorbidties. Blood advances 8 (3) (2024)
Morten Kranker Larsen, Vibe Skov, Lasse Kjær, Christina Schjellerup Eickhardt-Dalbøge, Trine Alma Knudsen, Marie Hvelplund Kristiansen, Anders Lindholm Sørensen, Troels Wienecke, Morten Andersen, Johnny T Ottesen, Johanne Gudmand-Høyer, Jordan Andrew Snyder, Mikkel Porsborg Andersen, Christian Torp-Pedersen, Henrik Enghusen Poulsen, Thomas Stiehl, Hans Carl Carl Hasselbalch, Christina Ellervik
Neutrophil-to-lymphocyte ratio and all-cause mortality with and without myeloproliferative neoplasms-a Danish longitudinal study. Blood cancer journal 14 (1) (2024)
Morten Orebo Holmström, Josephine Hallundbæk Ruders, Caroline Hasselbalch Riley, Morten Kranker Larsen, Jacob Handlos Grauslund, Lasse Kjaer, Vibe Skov, Christina Ellervik, Belinda B Guo, Matthew Linden, Hans Carl Carl Hasselbalch, Mads Hald Andersen
The CALR mutations enhance the expression of the immunosuppressive proteins GARP and LAP on peripheral blood lymphocytes through increased binding of activated platelets. British journal of haematology (2024)
Hans Carl Carl Hasselbalch, Vibe Skov, Lasse Kjaer, Morten Kranker Larsen
Proof of concept of triple COMBI therapy to prohibit MPN progression to AML. British journal of haematology (2023)
Marie Hvelplund Kristiansen, Lasse Kjær, Vibe Skov, Morten Kranker Larsen, Christina Ellervik, Hans Carl Carl Hasselbalch, Troels Wienecke
CHIP-JAK2V617F, Chronic Inflammation, Abnormal Megakaryocyte Morphology, Organ Failure, and Multimorbidties. Blood advances (2023)
Marie Hvelplund Kristiansen, Lasse Kjær, Vibe Skov, Morten Kranker Larsen, Christina Ellervik, Hans Carl Carl Hasselbalch, Troels Wienecke
JAK2V617F mutation is highly prevalent in patients with ischemic stroke: a case-control study. Blood advances (2023)
Morten Kranker Larsen, Vibe Skov, Lasse Kjaer, Natascha A Møller-Palacino, Rasmus K Pedersen, Morten Andersen, Johnny T Ottesen, Sabrina Cordua, Henrik E Poulsen, Morten Dahl, Trine A Knudsen, Christina Schjellerup Eickhardt-Dalbøge, Steffen Koschmieder, Kasper M Pedersen, Yunus Çolak, Stig Egil Bojesen, Børge G Nordestgaard, Thomas Stiehl, Hans Carl Carl Hasselbalch, Christina Ellervik
Clonal haematopoiesis of indeterminate potential and impaired kidney function-A Danish general population study with 11 years follow-up. European journal of haematology 109 (5) (2022)
Marc J B Dam, Rasmus Kristoffer Pedersen, Trine Alma Knudsen, Morten Andersen, Christina Ellervik, Morten Kranker Larsen, Lasse Kjaer, Vibe Skov, Hans Carl Carl Hasselbalch, Johnny T Ottesen
A novel integrated biomarker index for the assessment of hematological responses in MPNs during treatment with hydroxyurea and interferon-alpha2. Cancer medicine (2022)
Hans Carl Carl Hasselbalch, Vibe Skov, Lasse Kjær, Morten Kranker Larsen, Trine Alma Knudsen, Marko Lucijanic, Rajko Kusec
Recombinant Interferon-β in the Treatment of Polycythemia Vera and Related Neoplasms: Rationales and Perspectives. Cancers 14 (22) (2022)
Christina Schjellerup Eickhardt-Dalbøge, Anna Cäcilia Ingham, Lee O'Brien Andersen, Henrik Vedel Nielsen, Kurt Fuursted, Christen Rune Stensvold, Morten Kranker Larsen, Lasse Kjær, Sarah Friis Christensen, Trine Alma Knudsen, Vibe Skov, Christina Ellervik, Lars Rønn Olsen, Hans Carl Carl Hasselbalch, Xiaohui Chen Nielsen, Jens Jørgen Elmer Christensen
The Gut Microbiota in Patients with Polycythemia Vera is Distinct from that of Healthy Controls and Varies by Treatment. Blood advances (2022)